Wave Life Sciences Yönetim
Yönetim kriter kontrolleri 3/4
Wave Life Sciences CEO'su Paul B. Bolno, Dec2013 tarihinde atandı, in görev süresi 10.92 yıldır. in toplam yıllık tazminatı $ 3.87M olup, şirket hissesi ve opsiyonları dahil olmak üzere 16.4% maaş ve 83.6% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.14% ine doğrudan sahiptir ve bu hisseler $ 3.10M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.9 yıl ve 8 yıldır.
Anahtar bilgiler
Paul B. Bolno
İcra Kurulu Başkanı
US$3.9m
Toplam tazminat
| CEO maaş yüzdesi | 16.4% |
| CEO görev süresi | 10.9yrs |
| CEO sahipliği | 0.1% |
| Yönetim ortalama görev süresi | 3.9yrs |
| Yönetim Kurulu ortalama görev süresi | 8yrs |
Son yönetim güncellemeleri
Recent updates
US$22.20 - That's What Analysts Think Wave Life Sciences Ltd. (NASDAQ:WVE) Is Worth After These Results
Nov 15
Optimistic Investors Push Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Up 95% But Growth Is Lacking
Nov 09Wave Life Sciences: Positive WVE-006 Data For AATD Leads To 2025 Catalyst
Oct 16There's Reason For Concern Over Wave Life Sciences Ltd.'s (NASDAQ:WVE) Massive 43% Price Jump
Sep 25Wave Life Sciences: Spiking On Strong DMD Data, But Not Fully De-Risked Yet
Sep 24Broker Revenue Forecasts For Wave Life Sciences Ltd. (NASDAQ:WVE) Are Surging Higher
Sep 08We're Keeping An Eye On Wave Life Sciences' (NASDAQ:WVE) Cash Burn Rate
Aug 05Pinning Down Wave Life Sciences Ltd.'s (NASDAQ:WVE) P/S Is Difficult Right Now
Jun 25We Think Wave Life Sciences (NASDAQ:WVE) Can Easily Afford To Drive Business Growth
Apr 09Wave Life Sciences' Weighty Ambition: Carving Out Obesity Niche
Mar 09Wave Life Sciences Ltd.'s (NASDAQ:WVE) 30% Price Boost Is Out Of Tune With Revenues
Mar 03We're Interested To See How Wave Life Sciences (NASDAQ:WVE) Uses Its Cash Hoard To Grow
Sep 13Wave Life Sciences Ltd. (NASDAQ:WVE) Analysts Just Cut Their EPS Forecasts Substantially
May 08Here's Why Wave Life Sciences (NASDAQ:WVE) Must Use Its Cash Wisely
Mar 30Are Investors Undervaluing Wave Life Sciences Ltd. (NASDAQ:WVE) By 47%?
Jan 20Some Analysts Just Cut Their Wave Life Sciences Ltd. (NASDAQ:WVE) Estimates
Nov 11Is Wave Life Sciences (NASDAQ:WVE) In A Good Position To Deliver On Growth Plans?
Aug 12Wave Life Sciences Q2 2022 Earnings Preview
Aug 10Will Wave Life Sciences (NASDAQ:WVE) Spend Its Cash Wisely?
Apr 21Is Wave Life Sciences (NASDAQ:WVE) In A Good Position To Invest In Growth?
Jan 11CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$143m |
| Jun 30 2024 | n/a | n/a | -US$73m |
| Mar 31 2024 | n/a | n/a | -US$62m |
| Dec 31 2023 | US$4m | US$636k | -US$58m |
| Sep 30 2023 | n/a | n/a | -US$85m |
| Jun 30 2023 | n/a | n/a | -US$131m |
| Mar 31 2023 | n/a | n/a | -US$151m |
| Dec 31 2022 | US$3m | US$618k | -US$162m |
| Sep 30 2022 | n/a | n/a | -US$153m |
| Jun 30 2022 | n/a | n/a | -US$120m |
| Mar 31 2022 | n/a | n/a | -US$118m |
| Dec 31 2021 | US$4m | US$597k | -US$122m |
| Sep 30 2021 | n/a | n/a | -US$116m |
| Jun 30 2021 | n/a | n/a | -US$143m |
| Mar 31 2021 | n/a | n/a | -US$145m |
| Dec 31 2020 | US$1m | US$579k | -US$150m |
| Sep 30 2020 | n/a | n/a | -US$178m |
| Jun 30 2020 | n/a | n/a | -US$196m |
| Mar 31 2020 | n/a | n/a | -US$197m |
| Dec 31 2019 | US$4m | US$579k | -US$194m |
| Sep 30 2019 | n/a | n/a | -US$175m |
| Jun 30 2019 | n/a | n/a | -US$162m |
| Mar 31 2019 | n/a | n/a | -US$156m |
| Dec 31 2018 | US$6m | US$541k | -US$147m |
| Sep 30 2018 | n/a | n/a | -US$140m |
| Jun 30 2018 | n/a | n/a | -US$127m |
| Mar 31 2018 | n/a | n/a | -US$116m |
| Dec 31 2017 | US$3m | US$515k | -US$102m |
Tazminat ve Piyasa: Paul B. 'ın toplam tazminatı ($USD 3.87M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 5.54M ).
Tazminat ve Kazançlar: Paul B. şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.
CEO
Paul B. Bolno (50 yo)
10.9yrs
Görev süresi
US$3,874,300
Tazminat
Dr. Paul B. Bolno, M.D., MBA served as an Independent Director at SQZ Biotechnologies Company since June 2020 until March 2024. Since May 2020 he has served as Chairman of the Scientific Advisory Group for...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| President | 10.9yrs | US$3.87m | 0.14% $ 3.1m | |
| CFO & Principal Accounting Officer | 3.9yrs | US$1.70m | 0.029% $ 639.0k | |
| Chief Technology Officer | 4.5yrs | US$1.78m | 0.12% $ 2.6m | |
| Chief Scientific Officer | less than a year | Veri yok | Veri yok | |
| Head of Investor Relations | 5.6yrs | Veri yok | Veri yok | |
| Senior VP & General Counsel | 8.5yrs | Veri yok | Veri yok | |
| Senior VP of Corporate Development & Head of Emerging Areas | 7.8yrs | US$1.68m | 0% $ 0 | |
| Senior VP & Head of Human Resources | 1.8yrs | Veri yok | Veri yok | |
| Senior Vice President of Chemistry | 3yrs | Veri yok | Veri yok | |
| Chief Development Officer | 2.1yrs | Veri yok | Veri yok | |
| Senior Vice President of Translational Medicine | 1.8yrs | Veri yok | Veri yok |
3.9yrs
Ortalama Görev Süresi
51.5yo
Ortalama Yaş
Deneyimli Yönetim: WVE 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.9 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| President | 10.6yrs | US$3.87m | 0.14% $ 3.1m | |
| Director | 11.3yrs | US$170.74k | 0.020% $ 428.1k | |
| Independent Director | 5.2yrs | US$194.74k | 0.078% $ 1.7m | |
| Independent Chairperson | 8yrs | US$222.24k | 0.085% $ 1.8m | |
| Independent Director | 7.8yrs | US$188.74k | 0.085% $ 1.8m | |
| Independent Director | 9.8yrs | US$170.74k | 0% $ 0 | |
| Independent Director | 12.3yrs | US$170.74k | 0% $ 0 | |
| Independent Director | 5.2yrs | US$185.74k | 0.078% $ 1.7m | |
| Independent Director | 4.3yrs | US$172.24k | 0.069% $ 1.5m |
8.0yrs
Ortalama Görev Süresi
56yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: WVE 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8 yıldır).